ICER 2020 Priorities Include Drugs For Ulcerative Colitis NASH And Gene Therapies
ICER 2020 Priorities Include Drugs For Ulcerative Colitis, NASH And Gene Therapies
13:10 EDT 10 Jul 2019 |
SCRIP
The Institute for Clinical and Economic Review has a full agenda planned for 2020, starting with potential new oral drugs...
More From BioPortfolio on "ICER 2020 Priorities Include Drugs For Ulcerative Colitis, NASH And Gene Therapies"